Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 07, 2020

SELL
$334.87 - $493.06 $267,226 - $393,461
-798 Closed
0 $0
Q1 2020

Apr 23, 2020

SELL
$320.01 - $409.07 $67,202 - $85,904
-210 Reduced 20.83%
798 $280,000
Q4 2019

Jan 31, 2020

BUY
$319.73 - $374.2 $6,394 - $7,484
20 Added 2.02%
1,008 $373,000
Q3 2019

Nov 08, 2019

BUY
$304.55 - $345.24 $4,263 - $4,833
14 Added 1.44%
988 $329,000
Q2 2019

Aug 14, 2019

SELL
$286.93 - $312.59 $70,297 - $76,584
-245 Reduced 20.1%
974 $304,000
Q1 2019

May 10, 2019

BUY
$224.3 - $317.41 $273,421 - $386,922
1,219 New
1,219 $373,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.42B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Financial Counselors Inc Portfolio

Follow Financial Counselors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Counselors Inc with notifications on news.